Early clinical studies using cluster of differentiation 19 (CD19) CAR T cells revealed considerably significant toxicities compared to the symptoms experienced in conjunction with further cellular therapies, demonstrating substantially widespread stimulation of the immune system ( Table 2 ).
1
—
—